A cone snail venom peptide, μO §-conotoxin GVIIJ from Conus geographus, has a unique posttranslational modification, S-cysteinylated cysteine, which makes possible formation of a covalent tether of peptide to its target Na channels at a distinct ligandbinding site. μO §-conotoxin GVIIJ is a 35-aa peptide, with 7 cysteine residues; six of the cysteines form 3 disulfide cross-links, and one (Cys24) is S-cysteinylated. Due to limited availability of native GVIIJ, we primarily used a synthetic analog whose Cys24 was S-glutathionylated (abbreviated GVIIJ SSG ). The peptide-channel complex is stabilized by a disulfide tether between Cys24 of the peptide and Cys910 of rat (r) Na V 1.2. A mutant channel of rNa V 1.2 lacking a cysteine near the pore loop of domain II (C910L), was >10 3 -fold less sensitive to GVIIJ SSG than was wild-type rNa V 1.2. In contrast, although rNa V 1.5 was >10 4 -fold less sensitive to GVIIJ SSG than Na V 1.2, an rNa V 1.5 mutant with a cysteine in the homologous location, rNa V 1.5[L869C], was >10 3 -fold more sensitive than wildtype rNa V 1.5. The susceptibility of rNa V 1.2 to GVIIJ SSG was significantly altered by treating the channels with thiol-oxidizing or disulfide-reducing agents. Furthermore, coexpression of rNa V β2 or rNa V β4, but not that of rNa V β1 or rNa V β3, protected rNa V 1.1 to -1.7 (excluding Na V 1.5) against block by GVIIJ SSG . Thus, GVIIJrelated peptides may serve as probes for both the redox state of extracellular cysteines and for assessing which Na V β-and Na V α-subunits are present in native neurons.
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disulfide exchange | Na V β-subunit | tethered toxin | voltage-gated sodium channel | S-cysteinylation V oltage-gated sodium channels (VGSCs) are responsible for the upstroke of action potentials in excitable tissues. Each VGSC is composed of a pore-and voltage sensor-bearing α-subunit and one or more auxiliary β-subunits. Mammals have nine α-subunit isoforms (Na V 1.1 to -1.9) and four β-subunit isoforms (Na V β1 to -β4) (1) . An Na V 1 has about 2,000-aa residues arranged in four homologous domains, where each domain has six transmembrane spanning segments with an extracellular "pore" loop between segments 5 and 6 (1, 2); furthermore, each Na V 1 has about a dozen extracellular cysteine residues, all located in or near the pore loops. For the most part, not much is known about these cysteines (including whether they are disulfide bonded).
Na V β-subunits can affect the function and cellular localization of Na V 1s (1, (3) (4) (5) . Each Na V β-subunit has some 200-aa residues and consists of a single transmembrane segment with a large extracellular domain and a smaller intracellular domain (1) . Na V β2-and Na V β4-subunits, unlike Na V β1-and Na V β3-subunits, are disulfide bonded to α-subunits (1, 6) . A given neuron can have multiple isoforms of these subunits whose identities are challenging to appraise pharmacologically (7) .
Toxins that target VGSCs have been invaluable for probing the structure and function of these channels. Venoms are a rich source of such toxins. For example, in Conus snails, four families of neuroactive peptides have been characterized that target VGSCs: μ-conotoxins and μO-conotoxins, which block VGSCs by plugging the ion-conductance pore and preventing channel activation, respectively; and ι-conotoxins and δ-conotoxins, which promote channel activation and block channel inactivation, respectively. Members within each conotoxin family have homologous structures (8) (9) (10) . We have used μ-conotoxins to assess Na V 1-isoforms (7, 11) and both μ-and μO-conotoxins to examine the pharmacological impact of Na V β-subunit coexpression (12, 13) .
Previously unidentified μO §-conotoxin GVIIJ is the founding member of a fifth family of VGSC-targeting conotoxins. It is unusual among conopeptides in that it has an odd number of Cys residues in its primary amino acid sequence (Fig. 1 ). We present evidence that it potently blocks Na V 1-channels and that its "extra" cysteine residue, Cys24, is disulfide bonded to an extracellular Cys residue in the peptide's binding site on the channel, which we call "site 8" and which is distinct from previously identified neurotoxin-receptor sites 1 through 7 (14, 15) .
Results

Discovery of μO §-GVIIJ, Its Sequence, and Its Synthesis and That of Its
Analogs. We discovered μO §-GVIIJ by fractionating crude venom from Conus geographus by HPLC and assaying the eluate for activity against rNa V 1.7 exogenously expressed in Xenopus laevis oocytes (Fig. 1A) . A partial sequence of the peptide was obtained by conventional means, and the complete sequence was obtained Significance A biochemically unique cone snail venom peptide has been characterized that may be used to probe unexplored but important features of the diverse voltage-gated Na channel isoforms that underlie electrical signaling in the nervous system. This peptide has a unique posttranslational modification (S-cysteinylated cysteine) and blocks sodium channels by forming a disulfide bond with the channel at a distinctive binding site. Because block by the peptide is prevented when specific β-subunits are coexpressed, this neurotoxin has potential for assessing which β-subunits are present in native Na channels. Peptide activity depends on the oxidation state of extracellular Cys residues on the channel. Thus, this peptide can also be used to monitor the oxidation state of the targeted Na channels.
by searching the transcriptome of C. geographus (16) for sequences homologous to that of the peptide (Fig. 1B) . Tandem mass spectrometry confirmed the sequence and identified three posttranslationally modified residues: bromotryptophan, hydroxyproline, and S-cysteinylated cysteine (Fig. 1C and Figs. S2 and S3) . Because of limited availability of the native peptide, most of the experiments were done with the two derivatives: GVIIJ[W2W; C24C(glutathione)] and GVIIJ[W2W;C24C(free thiol)], hereafter referred to as GVIIJ SSG and GVIIJ SH , respectively (Fig. 1D) . Like the native peptide μO §-GVIIJ, the GVIIJ SSG analog has Cys24 in a disulfide linkage whereas the GVIIJ SH analog's Cys24 is in the free thiol form; thus, GVIIJ SH served as a reference to help investigate the role of the disulfide-bonded modification of Cys24. GVIIJ SSG blocked the voltage-gated currents (I Na ) of all tetrodotoxin-sensitive rNa V 1-subtypes (Na V 1.1 to -1.4, -1.6, and -1.7) with K d s ranging from 5 to 360 nM whereas the IC 50 for rNa V 1.5 was >200 μM (Table S3) . No block of rNa V 1.8 was observed at 100 μM, the highest concentration of the peptide tested. Similar results were obtained with human (h) Na V 1-subtypes stably expressed in human embryonic kidney (HEK) 293 or Chinese hamster ovary (CHO) cell lines (Table S4) .
GVIIJ SSG and GVIIJ SH were extensively tested on oocytes expressing rNa V 1.2. The recovery from block by GVIIJ SSG was invariably only very slowly reversible following washout of peptide ( Fig. 2A and Table S3 ) whereas the recovery from block by GVIIJ SH usually had two phases (Fig. 2B) , a very rapid phase and a much slower phase (k off = 2.0 ± 0.2 s −1 and 0.004 ± 0.003 s −1
(mean ± SD, n = 6 oocytes), respectively); the latter value is statistically the same as the k off of GVIIJ SSG (Table S3 ) (P = 0.57).
The native μO §-GVIIJ behaved like GVIIJ SSG insofar as its block of Na V 1.7 reversed very slowly (Figs. 1A and 2A and Table S3 ). (17) . Thus, MTSET treatment results in the attachment of an exogenous group, ET, to accessible free thiols on the channel via a disulfide bond. MTSET treatment completely protected the channel against block by GVIIJ SSG (Fig. 2C ). This protection was reversed by subsequent treatment of the oocytes with DTT (Fig. 2C) . In contrast to the protection against GVIIJ SSG , MTSET treatment of the oocytes converted the reversible block by GVIIJ SH to one that was exclusively very slowly reversible (Fig. 2D ), similar to that of GVIIJ SSG on untreated oocytes ( Fig. 2A) . At saturating concentrations, the level of block by GVIIJ SSG was smaller and more variable than that by GVIIJ SH ; however, the block by GVIIJ SSG was made less variable and increased to that by GVIIJ SH by treatment of oocytes with DTT (Fig. 3B) . The relative magnitude of the slow phase of recovery from block by GVIIJ SH varied from oocyte to oocyte (e.g., Fig. 2 B and D), and for a given oocyte it increased as the exposure time to GVIIJ SH increased (Fig. S4) .
When oocytes were exposed to CuPhen, which catalyzes air oxidation of thiols (18, 19) , the magnitude of block by GVIIJ SSG was decreased ( Fig. 3 A, b and B), and its off-rate accelerated ( Fig. 3 A, b) . In stark contrast, the main effect of CuPhen treatment on the block by GVIIJ SH was to make its off-rate very slow ( Fig. 3 A, b′) , similar to that following treatment with MTSET shown in Fig. 2D . (Note, unlike MTSET treatment, which adds an exogenous group to the free thiol of channel Cys residues, CuPhen-catalyzed air oxidation is expected to result in a disulfide linkage of two free thiol groups, presumably those of channel Cys residues that are in close proximity to each other.) Furthermore, the effects of CuPhen on the block by both peptides were largely reversed by subsequent treatment of oocytes with DDT ( Fig. 3 A, c and c′). The interactions between the peptides and the channel, modifiable by thiol-oxidizing and disulfide-reducing agents, are summarized in the hypothetical reaction scheme in Fig. 3C , which is described in detail in Discussion. The star indicates the area from where the native peptide was isolated. The Inset depicts the ability of the starred fraction to block sodium currents (I Na ) in an X. laevis oocyte expressing rNa V 1.7 that was voltage clamped at −80 mV and I Na evoked by a voltage step to −10 mV applied every 20 s (Materials and Methods): the major plot shows the time course of block (the bar represents when oocyte was exposed to the starred fraction)-note the very slow recovery from block when the fraction was washed out; the minor plot illustrates traces of I Na before and during block (large and attenuated responses, respectively). The amount of material applied to oocyte (in a 30-μL bath) was an equivalent of 2 mg of starting crude venom. (B) The complete sequence of prepro GVIIJ from transcriptome. The arrow indicates the signal cleavage site predicted by Signal P; the underlined sequence was independently obtained from targeted PCR; the "LDC" sequence after the arrow is part of the propeptide; mature toxin is shown in bold; the asterisk indicates the stop codon. (C) Sequence and posttranslational modifications of native peptide determined by tandem mass spectrometry, where W is bromotryptophan (presumably L-6-bromoTrp, a residue also found in other Conus peptides) (35, 36) , O is hydroxyproline,^indicates C-terminal free carboxyl group, and X 1 is cysteine (which is surmised to be disulfide bonded to the side-chain thiol of Cys24 based on the functional activities of synthetic analogs in D. (D) Synthetic analogs of GVIIJ with disulfide connectivities indicated by lines bridging Cys residues. X 2 represents glutathione (disulfide bonded to Cys24 in GVIIJ SSG ) or hydrogen (of the free thiol of Cys24 in GVIIJ SH ) or cysteine (disulfide bonded to Cys24 in GVIIJ SSC ). (E) RP-HPLC elution profiles of purified native GVIIJ (Left), synthetic GVIIJ (Center), and a mixture of both native and synthetic GVIIJ (Right) on an analytical C18 column with a gradient of 15-45% of solvent B (90% acetonitrile in 0.1% TFA) in 30 min at a flow rate of 1 mL/min. Methods and additional results are provided in SI Materials and Methods, Figs. S1-S3, Tables S1 and S2, and SI Appendix.
Mutating VGSCs Pinpoint the Location of a Cys Residue in the Binding
Site (Site 8). To help identify the cysteine(s) in the channel's active site, the amino acid sequences of rNa V 1.1 to -1.8 and those of hNa V 1.1 to -1.7 were aligned, and the locations of extracellular Cys residues were compared. The sequences of all Na V 1s that were highly sensitive to GVIIJ SSG have Cys residues at 14 extracellular locations (which are at identical homologous positions, except for rNa V 1.4, which has one fewer Cys residue). By comparison, Na V 1.5, which was very poorly blocked by the peptides, lacks three Cys residues located in the N-terminal region near the pore loop of domain II in the other Na V 1-isoforms. We constructed two complementary chimeras from hNa V 1.7 and 1.5: chimera 7577 (composed of domain II of hNa V 1.5 in an otherwise hNa V 1.7 background) and the reciprocal chimera 5755. The latter, like hNa V 1.7, was sensitive to GVIIJ SH whereas chimera 7577, like hNa V 1.5, was significantly less sensitive (Fig.  S5) , suggesting that one or more of these three cysteines may be involved in the peptide binding to the channel.
For rNa V 1.2, the trio of Cys residues in domain II are Cys910, Cys912, and Cys918, and the mutant rNa V Table S3 ). Treatment of oocytes expressing rNa V 1.2 [C910L] with MTSET had essentially no effect on the activity of either peptide (Fig. 2 G and H) , suggesting that Cys910 alone was largely responsible for the consequences of MTSET treatment of the wild-type channel seen in Fig. 2 C and D.
The rNa V 1.5 mutant with a Cys replacing Leu869 near the pore loop of domain II, rNa V 1.5[L869C], was expressed in oocytes and found to be significantly more sensitive than wild-type rNa V 1.5 to both GVIIJ SSG and GVIIJ SH (Fig. 4) . GVIIJ SSG had a >10 3 higher affinity for the mutant over the wild-type channel (Table S3) . Furthermore, in contrast to the rapidly reversible block of rNa V 1.5 by both peptides (Fig. 4 A and B) , the block of rNa V 1.5[L869C] was slowly reversible, with GVIIJ SSG being more slowly reversible than GVIIJ SH (Fig. 4 C and D) . These results further substantiate the importance of a cysteine near the pore loop of domain II in the active site, site 8, of the channel. Identification of Cys910 of rNa V 1.2 as a critical residue for both GVIIJ SSG and GVIIJ SH activity suggests that μO §-conotoxins act at a site different from those of members of the two other families of conotoxins that also block VGSCs: namely, μ-conotoxins and μO-MrVIA/B. As previously mentioned, Cys910 in Na V 1.2 is near the pore loop of domain II; in contrast, μ-conotoxins and TTX bind at site 1, closer to the channel's ionselectivity filter (14, 20, 21) , and the binding site of μO-MrVIA/B is near the voltage sensor of domain II (22, 23) (for reviews of neurotoxin receptor binding site designations, see refs. 14 and 15). Thus, TTX and μ-and μO-conotoxins might not be expected to compete with GVIIJ SSG . Lack of competition was experimentally verified with oocytes expressing rNa V 1.2 using TTX, μ-KIIIA[K7A], and μO-MrVIB (Fig. S6) . KIIIA[K7A] was used because, like TTX, it blocks by plugging the pore of the channel, but the plug is "leaky" (20, 24) and, at saturating concentrations of KIIIA[K7A], an ∼25% residual current (rI Na ) persists with Na V 1.2. This I Na was readily blocked by 3 μM GVIIJ SSG (Fig  S6B) , indicating that these two toxins occupy different sites on the channel. It should be noted that μ-KIIIA has 16 residues and is among the smallest μ-conotoxins; furthermore, KIIIA or KIIIA[K7A] can simultaneously occupy site 1 with TTX (20, 24) . It is possible a larger μ-conotoxin, such as μ-GIIIA (with 22 aa), might intrude into GVIIJ's binding space, insofar as mutation of cysteines near the pore loop of domain II of Na V 1.4 homologous to Cys912 and 918 of Na V 1.2 does affect μ-GIIIA binding to Na V 1.4 (25) (see also ref. 26) .
To test for competition between GVIIJ SSG and μO-MrVIB, we took advantage of the observation that strong depolarizing pulses accelerate the slow off-rate MrVIB (12) (Fig. S6C, Inset) , but not that of GVIIJ SSG (Fig. S6 C and D) . After sequential addition of these two peptides, regardless of their order of addition, the level of block that remained after strong depolarizing pulses (which "chased off" MrVIB) was similar and essentially that produced by exposure to GVIIJ SSG alone (Fig. S6 C and D) , which indicates that the two toxins do not share a common binding site.
Coexpression of Na V β2 or Na V β4 Protects VGSCs Against GVIIJ SH and GVIIJ SSG . We examined whether coexpression of rNa V β1-β4 with various rNa V 1s affected the activity of GVIIJ SSG . rNa V 1.7 coexpressed with either rNa V β1 or rNa V β3 was readily blocked by GVIIJ SSG (Fig. 5 A, B , and E and Table S3 ); in contrast, when coexpressed with either rNa V β2 or rNa V β4, rNa V 1.7 was completely resistant to block (Fig. 5 C-E) . Coexpression of rNa V 1.7 with binary combinations of rNa V β1 + rNa V β4 and rNa V β3 + rNa V β4 showed that expression of rNa V β4 was dominant in inducing resistance to block by GVIIJ SSG (Fig. 5E ). Finally, to see which parts of rNa V β2 conferred resistance to GVIIJ SSG , two β1:β2 chimeras were coexpressed with rNa V 1.7. Chimera β112 has the extracellular and transmembrane domains of rNa V β1 and the intracellular domain of rNa V β2 whereas chimera β211 has the extracellular domain of rNa V β2 on an otherwise rNa V β1 background (13) . rNa V 1.7 coexpressed with the β211, but not β112, chimera was insensitive to GVIIJ SSG (Fig. 5E) ; thus, the extracellular domain of rNa V β2 was responsible for conferring toxin resistance.
When coexpressed with rNa V β4, rNa V 1.1 through 1.6 were all rendered insensitive to 33 μM GVIIJ SSG , except rNa V 1.5, whose already-poor sensitivity was largely unaffected (Fig. 5F ). Likewise, the poor sensitivity of rNa V 1.2[C910L] toward GVIIJ SSG was minimally affected by rNa V β4 coexpression (Fig. 5F ).
Functional Properties of GVIIJ SSC and Synthetic μO §-GVIIJ. Only a limited number of experiments were performed with GVIIJ SSC (Fig. 1D with Cys for X 2 ) and synthetic μO §-GVIIJ itself because the S-cysteinylation of a Cys residue and the presence of bromoTrp were identified only after the electrophysiological experiments described above had been completed. Tests with rNa V 1.2 and -1.7 showed that the k on of GVIIJ SSC was 3.5-fold larger (for both Na V 1-isoforms) than that of GVIIJ SSG (Table S3) ; the smaller size of cysteine, relative to that of glutathione, might account for the larger on-rate of GVIIJ SSC . In contrast, the k off values of both peptides were essentially the same (Table S3) , which is expected; that is to say, for a given channel and peptide backbone, the identical peptide-channel complex is formed regardless of the SR-group disulfide bonded to Cys24 of the backbone because each peptide's respective SR group leaves when displaced by the thiol group of the channel cysteine during the process of disulfide exchange at site 8 (Fig. 3C) .
Discussion
Binding Site of μO §-GVIIJ. Site 8 is distinct from those of members of the two other families of conotoxins that also block VGSCs, μ-conotoxins (14, 20) and μO-conotoxins (22); consistent with this conclusion, μ-KIIIA and μO-MrVIB do not compete with GVIIJ SSG in blocking Na V 1.2 (Fig. S6) . Furthermore, site 8 can be modified by thiol-oxidizing and disulfide-reducing agents as summarized in Fig. 3C , which appears to be the most parsimonious scheme consistent with our results. The site exists in two basal states where, for one state (diagram a in Fig. 3C ), the block by GVIIJ SSG and GVIIJ SH is slowly and rapidly reversible, respectively, whereas, for the other state (diagram b in Fig. 3C , where SX is a channel cysteine), the converse is true. However, when SX in diagram b in Fig. 3C is ET, then GVIIJ SSG cannot block at all. These two interconvertible states can be driven by treatment with DTT in one direction and MTSET or CuPhen-catalyzed air oxidation in the other. Peptide binding results in three functionally blocked states; dissociation of the peptide occurs readily from two of the states (diagrams c and e in Fig. 3C ) and slowly from the third, disulfide-tethered state, which was achieved by disulfide exchange between peptide and channel (diagram d in Fig. 3C ).
It might be noted that, although most of the GVIIJ-sensitive Na V 1-isoforms block with high potency (K d = 5-50 nM), a standout is Na V 1.6 (K d = 360 nM), whose poor potency is largely due to its relatively large k off (Table S3) . Presumably, the disulfide tether between GVIIJ and Na V 1.6 is more labile, and it would be interesting to examine this further.
Both MTSET Treatment and Coexpression of Na V β2 or -β4 Inhibit the Block by GVIIJ SSG . Coexpression of Na V β2-and Na V β4-subunits, as well as MTSET treatment, produces the same effect; namely, the channels are protected against block by GVIIJ SSG . Unlike Na V β1 and Na V β3, which are noncovalently attached to their Na V 1-subunit, each of Na V β2 and Na V β4 is linked to its Na V 1-subunit via a disulfide bond (1, 6) . Thus, it is tempting to speculate that C910 of rNa V 1.2 might be disulfide-linked to its counterpart in Fig. 2 . Block by GVIIJ SSG and GVIIJ SH of rNa V 1.2 and rNa V 1.2[C910L] and effects of thiol-oxidizing and disulfide-reducing agents. Oocytes expressing either native or mutant channels were voltage-clamped as described in Fig. 1A. (A-H) Representative plots of peak sodium currents (I Na ) as a function of time before, during (indicated by bar above each plot), and after exposure to toxin. (A) GVIIJ SSG (10 μM) rapidly blocked I Na , which very slowly recovered during toxin washout. (Inset) Averages of five I Na traces obtained before, during, and after exposure to peptide (at t ∼ 2, 4, and 15 min, respectively). (B) Block by GVIIJ SH (1 μM) where recovery had fast and slow components. (C, D, G, and H) Vertical gray bars indicate when oocyte was exposed to 2 mM MTSET or 5 mM DTT, as indicated. Responses during washout of MTSET or DTT are not shown, accounting for blank area immediately following each vertical bar. (C) MTSET treatment prevented block by GVIIJ SSG , whose block is restored by subsequent DDT treatment to produce a slowly reversible block like that in A. (D) Initial exposure to GVIIJ SH produced a block that was essentially completely reversible, and MTSET treatment did not prevent block; on the contrary, the block was now only very slowly reversible, resembling that of GVIIJ SSG in A. (E and F) Block of Na V 1.2[C910L] mutant channel by GVIIJ SSG (E) and GVIIJ SH (F) was attenuated and transient. (G and H) MTSET treatment of mutant channel affected the activities of neither GVIIJ SSG (G) nor GVIIJ SH (H); note that both magnitude and time course of block remained essentially unaltered. Fig. 3 . Effects of CuPhen-catalyzed air oxidation of rNa V 1.2 on the block by GVIIJ SSG and proposed reaction scheme accounting for the behavior of GVIIJ and its analogs on channels treated with oxidizing and reducing agents. Oocytes expressing rNa V 1.2 were voltage-clamped as described in Fig. 1A. (A) Representative time course of block by indicated peptide plotted as in Fig. 2 . Treatment of oocytes with CuPhen (100 μM for 1 h) highly attenuated the block by GVIIJ SSG and converted the slowly reversible block in control (a) to one that was mostly rapidly reversible (b). In contrast, CuPhen treatment converted the rapidly reversible block by GVIIJ SH (a') to one that was largely slowly reversible (b'). These effects of CuPhen were largely reversed by subsequent DTT treatment of oocytes with 2 mM DTT for 1h (c and c'). Each plot is from a different oocyte. (B) Relative to controls (white bars), DTT-treatment of oocytes (2 mM for 1 h, black bars) increased the maximum block by GVIIJ SSG (33 μM) but not that by GVIIJ SH. (10 μM); furthermore, DTT treatment reduced the variability of block by GVIIJ SSG . In contrast, the Cu 2+ -phenanthroline (CuPhen) treatment (gray bars) decreased the maximum block by GVIIJ SSG whereas that by GVIIJ SH was more modestly decreased. Bars represent mean ± SD (n ≥ 8 oocytes). *, The first bar is lower than the second bar, P < 0.0002; heights of the second, fourth, and fifth bars are not significantly different from each other (P > 0.5). (C) Hypothesized states of site 8, wherein P represents the peptide either as PSH (i.e., GVIIJ SH ) or as PS-SR where Cys24 is disulfide bonded to R, which is either cysteine (GVIIJ SSC Na V β2 or Na V β4, a possibility also raised by Chen et al. for Na V β2 based on other considerations (6) .
Although Na V β2-or Na V β4-subunit coexpression protected against the block by both GVIIJ SH and GVIIJ SSG , MTSET treatment actually enhanced the block by GVIIJ SH (i.e., rendered it less reversible) (Fig. 2D) , an explanation for which is depicted in Fig. 3C . The difference between the consequences of Na V β2-or Na V β4-subunit coexpression and MTSET treatment could be explained by steric hindrance, in view of the large disparity in size between a β-subunit versus ET and that between a proton in GVIIJ SH versus glutathione in GVIIJ SSG (Fig. 1D) .
It should be noted that coexpression versus association of α-and β-subunits per se are not synonymous; thus, for example, Na V β1 coexpression can affect the glycosylation of the α-subunit (27) , and the glycosylation state of the α-subunit, rather than its physical association with a β-subunit, could be responsible for the altered pharmacology of the VGSC.
It remains to be shown whether the effects of Na V β-subunit coexpression in X. laevis oocytes is also manifested in mammalian expression systems and in neurons. Differences between VGSCs expressed in oocytes versus HEK cells with regard to Na V β-subunit coexpression have been observed; for example, in oocytes, the rate of fast inactivation of Na V 1.7 coexpressed with either Na V β1 or -β3 is faster than that of Na V 1.7 expressed alone (13, 28) . This result was not observed when HEK 293 cells served as the expression system, where coexpression of any Na V β isoform (Na V β1 to -β4) had no effect on the kinetics of Na V 1.7 currents (29).
Other Unresolved Issues. The incomplete block of sodium current, i.e., the residual current (rI Na ), that persists in the presence of saturating concentrations of GVIIJ SSG or GVIIJ SH is not understood. The maximum block produced by either peptide is about 90% (Fig. 3B) . It could result from either (i) heterogeneity of the channel-i.e., ∼10% of the channels are resistant to block, or (ii) incomplete, or partial, efficacy of block. Heterogeneity may play a role to some extent insofar as DDT treatment of oocytes can increase the efficacy of the block by GVIIJ SSG (although not that by GVIIJ SH ). The rI Na with GVIIJ SSG is ∼30% for Na V 1.2, -1.3, -1.4, -1.6, and -1.7 ( Fig. 5 E and F) ; however, that for Na V 1.1 is about twice as large (Fig. 5F ). For all of these Na V 1-isoforms, DTT treatment reduces the residual current to about 10%, like that shown for Na V 1.2 in Fig. 3B .
The mechanism by which binding of GVIIJ results in block of the channel remains to be determined. GVIIJ SSG is not a classical pore blocker. GVIIJ SSG is able to block Na V 1.2 with the IFM→QQQ mutation (in the linker between domains III and IV) that removes fast inactivation (30) (Fig. S7 ), but the peptide may stabilize the channel in some other inactivated state, such as a slow-inactivated state that may involve conformational coupling between the pore and voltage-sensor domains (31) . Alternatively, the GVIIJ peptides may inhibit channel activation by interfering with the channels' voltage sensors, similar to what gating modifiers such as μO-MrVIB, Protox II, and HwTx-IV do (22, 23, (32) (33) (34) , but possibly allosterically. It might be noted that, at saturating toxin concentrations, the level (or efficacy) of block of Na V 1.7 by Protox II and of Na V 1.4 by HwTx-IV are 95% (32) and 41% (34) , respectively, and they may represent precedents for the partial efficacy of block manifested by the GVIIJ peptides.
In conclusion, μO §-GVIIJ provides an exciting tool with which to explore the pharmacology, structure, and function of VGSCs. Fig. 4 . Block of rNa V 1.5 and rNa V 1.5[L869C] by GVIIJ SSG and GVIIJ SH . Representative voltage-clamp records were acquired from oocytes as described in Fig. 1A . (A and B) GVIIJ SSG (33 and 100 μM) and GVIIJ SH (10 μM) poorly blocked I Na of Na V 1.5, and, in each case, the time course of recovery upon peptide washout was too fast to accurately measure. (C and D) GVIIJ SSG (33 μM) and GVIIJ SH (10 μM) each blocked Na V 1.5[L869C] significantly greater than wild-type Na V 1.5. Furthermore, recovery of Na V 1.5[L869C] during peptide washout was slow (k off = 0.0039 ± 0.0032 min − 1 for GVIIJ SSG , and biphasic for GVIIJ SH where k off = 1.2 ± 0.6 min − 1 and k' off = 0.06 ± 0.04 min − 1 ; mean ± SD, n ≥ 3 oocytes). Fig. 5 . Coexpression of rNa V β2 or -β4, but not rNa V β1 or -β3, prevented block by GVIIJ SSG of all rNa V 1-isoforms except Na V 1.5 and Na V 1.2[C910L]. Records were acquired from oocytes as described in Fig. 1A. (A-D) Representative time course of block by GVIIJ SSG of Na V 1.7 coexpressed with Na V β1 to -β4 (the Inset in A shows Na V 1.7 expressed alone). (E and F) Levels of steadystate block (mean ± SD, n ≥ 3 oocytes). (E) Block by 33 μM GVIIJ SSG of Na V 1.7 coexpressed with individual Na V βs, binary Na V β combinations, and Na V β1:β2 chimeras (β112 and β211). (F) Comparison of the block by GVIIJ SSG of Na V 1.1 to -1.6 and Na V 1.2[C910L] without and with Na V β4 coexpression. Peptide concentration was 33 μM throughout, except for Na V 1.3, -1.4, and -1.6 without Na V β4 coexpression, where the concentration was 10 μM. The first gray bar is lower than second gray bar (P < 0.001), and the heights of the third, fourth, and sixth gray bars are not different from that of the second gray bar (P > 0.05) by t test.
